Found: 54
Select item for more details and to access through your institution.
Long‐term outcomes in light chain deposition disease‐analysis of a UK cohort.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E444, doi. 10.1002/ajh.26725
- By:
- Publication type:
- Article
Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first‐line treatment of systemic light chain amyloidosis in the UK.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 537, doi. 10.1111/ejh.13582
- By:
- Publication type:
- Article
The value of screening biopsies in light‐chain (AL) and transthyretin (ATTR) amyloidosis.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 352, doi. 10.1111/ejh.13458
- By:
- Publication type:
- Article
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 3, p. 230, doi. 10.1111/ejh.13366
- By:
- Publication type:
- Article
A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantation.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 1, p. 98, doi. 10.1111/ejh.12988
- By:
- Publication type:
- Article
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.703233
- By:
- Publication type:
- Article
99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2021, v. 22, n. 11, p. 1304, doi. 10.1093/ehjci/jeab095
- By:
- Publication type:
- Article
Prognostic utility of the Perugini grading of <sup>99m</sup>Tc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2017, v. 18, n. 12, p. 1344, doi. 10.1093/ehjci/jew325
- By:
- Publication type:
- Article
P-129: Quality of life reported outcomes in published research on AL Amyloidosis: a systematic literature review.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S105, doi. 10.1016/S2152-2650(21)02256-4
- By:
- Publication type:
- Article
P-024: Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S52, doi. 10.1016/S2152-2650(21)02158-3
- By:
- Publication type:
- Article
OAB-047: Plasma cell disorder patients are left vulnerable after one dose of the BNT162b2 mRNA or the ChAdOx-nCOV-19 COVID-19 vaccines.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S30, doi. 10.1016/S2152-2650(21)02121-2
- By:
- Publication type:
- Article
Ixazomib, lenalidomide and dexamethasone in relapsed AL amyloidosis – a first report.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e309, doi. 10.1016/j.clml.2019.09.508
- By:
- Publication type:
- Article
Real World Use of Ixazomib With Lenalidomide and Dexamethasone for Patients With Relapsed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e264, doi. 10.1016/j.clml.2019.09.436
- By:
- Publication type:
- Article
Comparison of PET Reconstruction Algorithms on Assessment and Quantification of FDG-PETCT Findings in Patients with Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e171, doi. 10.1016/j.clml.2019.09.286
- By:
- Publication type:
- Article
Clinical Profiles and Outcomes in 1203 Newly Diagnosed Patients With Systemic AL Amyloidosis – First Analysis of the ALChemy Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e21, doi. 10.1016/j.clml.2017.03.037
- By:
- Publication type:
- Article
Length of Hospital Stay is an Independent Predictor of Overall Survival in Patients with systemic AL Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e109, doi. 10.1016/j.clml.2017.03.198
- By:
- Publication type:
- Article
Finite Element Approximation of Fluid‐Structure Interaction with Coupled Wave Propagation.
- Published in:
- PAMM: Proceedings in Applied Mathematics & Mechanics, 2017, v. 17, n. 1, p. 511, doi. 10.1002/pamm.201710225
- By:
- Publication type:
- Article
Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis.
- Published in:
- Nephrology Dialysis Transplantation, 2018, v. 33, n. 2, p. 241, doi. 10.1093/ndt/gfw375
- By:
- Publication type:
- Article
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00717-2
- By:
- Publication type:
- Article
Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00510-7
- By:
- Publication type:
- Article
The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2187, doi. 10.1093/eurheartj/ehad139
- By:
- Publication type:
- Article
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.
- Published in:
- European Heart Journal, 2022, v. 43, n. 45, p. 4722, doi. 10.1093/eurheartj/ehac363
- By:
- Publication type:
- Article
Bendamustine in combination with thalidomide and dexamethasone is an effective therapy for myeloma patients with end stage renal disease.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 5, p. 632, doi. 10.1111/j.1365-2141.2011.08754.x
- By:
- Publication type:
- Article
Leukaemia cutis with chronic myelomonocytic leukaemia.
- Published in:
- 2009
- By:
- Publication type:
- Other
Deep phenotyping of p.(V142I)‐associated variant transthyretin amyloid cardiomyopathy: Distinct from wild‐type transthyretin amyloidosis?
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 383, doi. 10.1002/ejhf.3088
- By:
- Publication type:
- Article
Response rates to second‐line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib‐based regime.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 138, doi. 10.1111/bjh.19529
- By:
- Publication type:
- Article
Real‐world efficacy of single‐agent belantamab mafodotin in relapsed systemic AL amyloidosis.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1811, doi. 10.1111/bjh.19286
- By:
- Publication type:
- Article
Is there a representative quality‐of‐life questionnaire for patients with AL amyloidosis?—systematic literature review.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 289, doi. 10.1111/bjh.18860
- By:
- Publication type:
- Article
Linking changes in quality of life to haematologic response and survival in systemic immunoglobulin light‐chain amyloidosis.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 3, p. 422, doi. 10.1111/bjh.18645
- By:
- Publication type:
- Article
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light‐chain amyloidosis.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 2, p. 328, doi. 10.1111/bjh.18216
- By:
- Publication type:
- Article
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV‐19 COVID‐19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. e21, doi. 10.1111/bjh.17864
- By:
- Publication type:
- Article
Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light‐chain (AL) amyloidosis.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 6, p. 1016, doi. 10.1111/bjh.17706
- By:
- Publication type:
- Article
Development of antibody response to SARS‐CoV‐2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 5, p. 857, doi. 10.1111/bjh.17441
- By:
- Publication type:
- Article
Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real‐world longitudinal data.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 587, doi. 10.1111/bjh.17636
- By:
- Publication type:
- Article
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. 643, doi. 10.1111/bjh.16401
- By:
- Publication type:
- Article
A 24‐year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 642, doi. 10.1111/bjh.16143
- By:
- Publication type:
- Article
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 638, doi. 10.1111/bjh.16122
- By:
- Publication type:
- Article
Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 3, p. 460, doi. 10.1111/bjh.15955
- By:
- Publication type:
- Article
Bioimpedance vector analysis for the detection of extracellular volume overload and sarcopenia in systemic AL amyloidosis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 977, doi. 10.1111/bjh.15675
- By:
- Publication type:
- Article
Real world outcomes of pomalidomide for treatment of relapsed light chain amyloidosis.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 4, p. 557, doi. 10.1111/bjh.15541
- By:
- Publication type:
- Article
Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 1, p. 145, doi. 10.1111/bjh.14747
- By:
- Publication type:
- Article
Immunoparesis defined by heavy+light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosis.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 4, p. 575, doi. 10.1111/bjh.14908
- By:
- Publication type:
- Article
Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 6, p. 842, doi. 10.1111/bjh.12973
- By:
- Publication type:
- Article
Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 842, doi. 10.1111/bjh.12973
- By:
- Publication type:
- Article
Alemtuzumab-based reduced-intensity conditioning allogeneic tranplantation for myeloma and plasma cell leukemia -- a single institution experience.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Transplantation for Myeloma and Plasma Cell Leukemia - A Single- Institution Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 242, doi. 10.1016/j.clml.2011.03.004
- By:
- Publication type:
- Article
Comparison of Free Light Chain Assays: Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain Amyloidosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparison of Free Light Chain Assays.
- Published in:
- American Journal of Clinical Pathology, 2016, v. 146, n. 1, p. 78, doi. 10.1093/AJCP/AQW079
- By:
- Publication type:
- Article
Analysis of the TTR gene in the investigation of amyloidosis: A 25‐year single UK center experience.
- Published in:
- Human Mutation, 2019, v. 40, n. 1, p. 90, doi. 10.1002/humu.23669
- By:
- Publication type:
- Article